Dr. Zoltan Takacs uses a ThinkPad to analyze some of the world's deadliest toxins and turn them into medicine leads.
Most people avoid venomous creatures. Dr. Zoltan Takacs has spent his life chasing them.
The renowned scientist and explorer seeks out the venoms of some of the world’s deadliest creatures — snakes, spiders, scorpions and more — with the hope that their lethal toxins will provide a template for designing new medicines. The basic logic behind his method: What can kill you just might save your life.
BinaxNOW Ag is now available over-the-counter, bringing accessible COVID-19 rapid self-testing to the masses.
Blog
Through the course of the COVID-19 pandemic, we've needed answers.
We've filed into long lines, ventured to doctors' offices and urgent care clinics, waited days for results or for home tests to arrive by mail, and postponed gatherings, celebrations and holidays.
Now, those much-needed answers will be in your hands.
Managing diabetes with FreeStyle Libre tech will be easier with partners for insulin delivery, online coaching.
Blog
As we have continued to expand the FreeStyle franchise of diabetes care systems — from testing strips to the first generation FreeStyle Libre continuous glucose monitor (CGM) to the FreeStyle Libre 2 integrated system and our latest next-gen FreeStyle Libre 3, approved for use in Europe — we are also working to expand offerings from leadi
Mobile video content enhances remote training and counseling for TB management
Article
Tuberculosis (TB) has been treatable for the past 60 years, yet remains a leading cause of death worldwide.1 In 2018 alone, 10 million people fell ill with TB, and 1.5 million people died from the disease.2 Many countries have run TB control programs for decades and achieved good results, but global eradication is distant. The TB treatment regimen prescribed by the World Health Organization is painful and lengthy, requiring at least six months of adherence. Getting patients to adhere to this regimen is a challenge.
FDA Emergency Use Authorization permits asymptomatic, non-prescription, over-the-counter self use for people with or without symptoms
The BinaxNOW COVID-19 Self Test is identical to the professional-use test, used since August 2020, bringing the most studied and widely used rapid antigen test to retail shelves across the country
BinaxNOW Self Test will be available nationwide and in large quantities at major food, drug and mass merchandiser retailers nationally and will be priced affordably, similar to common over-the-counter (OTC) tests
Together with vaccines, serial testing of asymptomatic people will help restore a sense of safety in everyday settings where people gather
Asymptomatic multi-test authorization also applies to BinaxNOW professional-use test
Press Release
FDA Emergency Use Authorization permits asymptomatic, non-prescription, over-the-counter self use for people with or without symptoms
The BinaxNOW COVID-19 Self Test is identical to the professional-use test, used since August 2020, bringing the most studied and widely used rapid antigen test to retail shelves across the country
BinaxNOW Self Test will be available nationwide and in large quantities at major food, drug and mass merchandiser retailers nationally and will be priced affordably, similar to common over-the-counter (OTC) tests
Together with vaccines, serial testing of asymptomatic people will help restore a sense of safety in everyday settings where people gather
Asymptomatic multi-test authorization also applies to BinaxNOW professional-use test
Our Pandemic Defense Coalition is here to help stop future pandemics in their tracks through global partnership.
Blog
We think it's safe to say, nobody ever wants to endure another pandemic. COVID-19 emphasized the importance of preparedness and containing viral threats before they reach every corner of the world.
Donation Kicks Off Fundraising Efforts for Education and Logistics Through VProject
Press Release
PERRYSBURG, OH, April 7, 2021 /3BL Media/ – O-I Glass, Inc. (NYSE: O-I) announced today that it has gifted $50k to the Victory Over COVID-19 Through Vaccination (VProject) through its O-I Charitable Foundation. As Northwest Ohio prepares to enter Phase 1B for vaccine distribution, the VProject is engaging more than 250 community leaders to ensure vaccine access and information to all populations represented in the area.
